Company Reports

DB: Dead & Buried?

09/26/2016

Deutsche Bank is about to pierce stock single digits as its mounting woes magnify. Viola Risk was warning of this back in early August and we will have a series of more articles on the death spiral developing.


Wells Fargo: Allís Well That Ends Well? Not!

09/19/2016

WFC’s stakeholder stack needs answers from the C-suite as to what are the new financial metric strategy, targets, goals and mantra now that cross-selling has failed in its mission to accrete shareholder value and induce bondholder/risk manager security. 

At this point we continue to believe that Wells Fargo is a systemically strong company that has created enormous shareholder value over the last ten years, more so than any bank in the US and the world. We recommend buying at these lower stock and bond/cds levels. Maintain counterparty risk exposures. WFC WFC Wells Fargo Wells Fargo


Deutsche Bk: Death March Math, Capital Whacked By Level 3s

08/29/2016

Deutsche Bank's desperate situation is further imperiled by its seriously illiquid Level 3 assets. In the last 2 years, there has been a de minimus amount of outflows whether payments, maturities or more importantly sales. This is a bad sign as DB is in desperate need of capital now, not over long-time periods that the Level 3s are schedule to pay off on. We believe that opportunistic investors would pay very little to “no bid” on these highly complex and customized structures with no market liquidity.  DB DB DB Deutsche Deutsche Deutsche


Deutsche Bank: The Rise & Fall of the Fourth Bkg Reich

08/02/2016

The Viola Risk Advisor "systemic risk" indicator shows Deutsche Bank's desperate situation. Based on this metric, it would take DB roughly 14 years to rebuild its capital shortfall with core operating earnings compared to U.S. big banks (~2 years) & Canadian banks (~ 1 year).


MS 2Q16: Slaughter Old Goats, Heard Young Lambs

07/21/2016

MS turning around its Shareholder Value-Added trend to the positive which should boost its Stakeholder Stack values across equity & debt. Regulatory risk highest of majors.


BAC 2Q16: Same Old Swaps Story, Desperate For HY Assets

07/20/2016

Bank of America is hitting the profits wall yet again and resorting to its Swaps schemes to jumpstart sagging earning asset yields. Still, it was not willing to reveal the extent of that strategy. Negative EVA continues to rot its shareholder values. BAC BAC


GS 2Q16: Grasping for Golden Touch, Slumminí w/ Consumer Finance Types

07/20/2016

Goldman Sachs posted mediocre results as the financial markets crapped out on them. Looking for revs stability in consumer finance. What? 


PNC 2Q16: Low Systemics/EVAs, Buy LT Bonds/Stock

07/18/2016

PNC has done a good job as a big regional bank building its EVA and reducing systemic risk. Find value in bonds given low yield environment. Stock has legs too. PNC PNC


WFC 2Q16: EVA Titan, Not Systemic, But Lots of Energy

07/18/2016

Wells Fargo has the strongest EVA & Systemic buffers of any bank in the U.S. & the world. We believe this supports a stock Buy and a Buy on its credit spectrum across debt/counterparty/regulatory. WFC WFC Wells Fargo Wells Fargo


C 2Q16: Detox & Botox @ EVA Spa

07/18/2016

Citi keeps honking its horn that it has turned the corner, but still it has glitches in Costco integration. EVA improving, but still digging out of a deep shareholder value ditch. Buy Stock for LT breakup value, select bonds.


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38